← boothcheck

Is CMRE overvalued?

boothcheck doesn't label CMRE overvalued or undervalued and publishes no house fair value, target price, or buy/sell rating. Individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. In the published model solve dated 2026-07-29T16:51:57.294Z, anchored at $15.24, the CMRE price sits below the model's tested range at its stated assumptions: even the steepest tested decline path leaves model value above the price, and the exact break-even path was not resolved. The price is supported by asset-based and earnings-power and relative-multiple value. A value/asset-supported name, not a pure growth bet. The report narrative was composed 2026-07-25. The more the price assumes beyond what COSTAMARE INC. has actually delivered, the more has to go right to justify it. Whether that bar is too high is your call, and the full bull and bear cases are in the report.

Derived from COSTAMARE INC.'s SEC EDGAR filings via a reverse-DCF inversion. Last analyzed July 25, 2026.

Model readbeyond tested decline range
Price vs asset value0.46x
Price vs earnings power0.49x
Price vs peer multiples0.37x
Price vs forward growth1.41x
Read the full CMRE report →
Get boothcheck's read on what CMRE's price is betting on, in your inbox when it moves. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.